• Although social isolation measures and adaptation of the healthcare system slowed the progress of the COVID-19 pandemic, no effective treatments are available for severe lung complications. • Optical theranostics methods can identify COVID-19 pulmonary manifestations and provide automated and real-time control of the treatment dosimetry as well as flexibility for combination with existing medical devices and drug repurposing protocols. • Implementation of reliable and safe theranostics methods requires strong collaboration among researchers, industry and medical institutions.